Syncope, Vasovagal, Neurally-Mediated
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Syncope, Vasovagal, Neurally-Mediated trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Syncope, Vasovagal, Neurally-Mediated trials you may qualify forThe third study on CardNM (CardNMH3 study) is a multicenter, double-blind, randomized trial with a sham control group investigating the efficacy and safety of a…
The aim of this study is to assess the efficacy of a therapeutic strategy aimed to increase 24-hour systolic blood pressure (SBP) values, assessed by 24-hour am…
Syncope is a common presenting condition. Pacemaker implantation can significantly reduce syncope recurrences in reflex syncope. However, despite careful select…
ISSUE 3 is a multi-center, prospective, randomised controlled double-blind study aimed to assess the effectiveness of pacemaker therapy for prevention of asysto…
Syncope is a major health problem. In the emergency department (ED), the management of patients with syncope still remains a clinical challenge because underlyi…
Cardioneuroablation is a novel treatment option for reflex-mediated syncope. It involves thermal destruction of neural tissue in the close proximity of heart us…